Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Dividend Yield Fund median (12 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 03 Apr 2006 – 20 Aug 2026. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one. Nifty 500 history starts 25 Jul 2016, so that benchmark is not plotted over this window — pick a shorter range to see it.
View as table
| Date | UTI - Dividend Yield Fund |
|---|---|
| 03 Apr 2006 | ₹100.00 |
| 14 Dec 2007 | ₹124.07 |
| 26 Aug 2009 | ₹89.45 |
| 08 May 2011 | ₹109.73 |
| 17 Jan 2013 | ₹104.98 |
| 30 Sep 2014 | ₹121.65 |
| 11 Jun 2016 | ₹111.83 |
| 21 Feb 2018 | ₹127.74 |
| 04 Nov 2019 | ₹118.91 |
| 16 Jul 2021 | ₹156.14 |
| 28 Mar 2023 | ₹150.43 |
| 08 Dec 2024 | ₹259.23 |
| 20 Aug 2026 | ₹248.67 |
| Metric | UTI · Regular · IDCW NAV ₹33.47 Very High risk ★★★☆☆ | Category median Dividend Yield Fund · 12 funds |
|---|---|---|
| -2.38% | -1.33% | |
| +11.69% | +9.44% | |
| +8.87% | +8.87% | |
| +7.97% | +4.84% | |
| +4.57% | +4.58% | |
| +9.21% | — | |
| +6.28% | +10.02% | |
| +5.43% | +5.64% | |
| +4.57% | +4.20% | |
| Risk | ||
| 12.80% | 15.15% | |
| 0.41 | 0.04 | |
| 0.55 | 0.06 | |
| -56.24% | -23.07% | |
| Nifty 500 | — | |
| +0.20% | -2.04% | |
| 0.92 | 0.94 | |
| 95.4% | 87.3% | |
| 93.7% | 99.0% | |
| 1.98% | 2.29% | |
| ₹3,728Cr | ₹1,253Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹5.00K | — | |
| 8% | 8% | |
| Amit Premchandani | — | |
| 03 Apr 2006 | — | |
| 54 | — | |
| 36.6% | — | |
| 1.4% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.